Assignee
REMEDY PHARMACEUTICALS INC
US·7 granted patents·12 pending applications·13 citations·filing 2014–2025
Top patents by PatentIndex Score
19 records- 0197US12251389B1Methods of treating ischemic stroke at risk for cerebral or cerebellar edemaREMEDY PHARMACEUTICALS INC·Filed 2024·Granted Mar 18, 2025·6 cites·30 claims
- 0295US12251388B1Methods of treating ischemic stroke at risk for cerebral or cerebellar edemaREMEDY PHARMACEUTICALS INC·Filed 2024·Granted Mar 18, 2025·4 cites·14 claims
- 0385US12226521B2Methods of intravenous administration of glyburideREMEDY PHARMACEUTICALS INC·Filed 2023·Granted Feb 18, 2025·0 cites·20 claims
- 0485US2025017880A1Methods of treating injuries or conditions related to cns edemaREMEDY PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0584US9254259B2Methods of intravenous administration of glyburideREMEDY PHARMACEUTICALS INC·Filed 2014·Granted Feb 9, 2016·3 cites·63 claims
- 0683US2025345347A1Methods of treating ischemic stroke at risk for cerebral or cerebellar edemaREMEDY PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0782US2024216309A1Methods of treating injuries or conditions related to cns edemaREMEDY PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0879US2025339448A1Methods of treating ischemic stroke at risk for cerebral or cerebellar edemaREMEDY PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0978US12337006B1Methods of treating ischemic stroke at risk for cerebral or cerebellar edemaREMEDY PHARMACEUTICALS INC·Filed 2025·Granted Jun 24, 2025·0 cites·30 claims
- 1076US2025221924A1Methods of intravenous administration of glyburideREMEDY PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1173US12496306B2Low-sorbing glyburide formulation and methodsREMEDY PHARMACEUTICALS INC·Filed 2024·Granted Dec 16, 2025·0 cites·26 claims
- 1273US2026021118A1Low-sorbing glyburide formulation and methodsREMEDY PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1368US2025161330A1Methods of medical treatment with sur1-trpm4 channel inhibitorsREMEDY PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1464US2025262227A1Low-sorbing glyburide formulation and methodsREMEDY PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1563US9561176B2Methods of intravenous administration of glyburideREMEDY PHARMACEUTICALS INC·Filed 2015·Granted Feb 7, 2017·0 cites·32 claims
- 1659US2025345346A1Methods of treating ischemic stroke at risk for cerebral or cerebellar edemaREMEDY PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1750US2025170151A1Low-sorbing glyburide kit, formulation and methodsREMEDY PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1848US2025325504A1Methods of treating ischemic stroke at risk for cerebral or cerebellar edemaREMEDY PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1946US2025325564A1Methods of treating ischemic stroke at risk for cerebral or cerebellar edemaREMEDY PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when REMEDY PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →